JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Research Grade Tigatuzumab is a humanized monoclonal antibody which targets human Tumor necrosis factor receptor superfamily member 10B (TRAIL-R2, CD262).